Patents/Assignees

GW Research Limited

13 patents in portfolio

US12150927utility2024
Use of Cannabidiolic Acid in the Treatment of Autism Spectrum Disorder and Associated Disorders
0 cites
US11963937utility2024
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US11944600utility2024
Use of Cannabinoids in the Treatment of a Neurodegenerative Disease or Disorder
0 cites
US11865102utility2024
Cannabidiol Preparations and Its Uses
0 cites
US11806319utility2023
Pharmaceutical Composition Comprising a Cannabinoid
0 cites
US11793770utility2023
7-oh-cannabidiol (7-OH-CBD) And/or 7-oh-cannabidivarin (7-OH-CBDV) for Use in the Treatment of Epilepsy
0 cites
US11766411utility2023
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US11752111utility2023
Use of Cannabidivarin in the Treatment of Autism Spectrum Disorder, Associated Disorders and Schizophrenia
0 cites
US11701330utility2023
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US11684598utility2023
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US11679087utility2023
Use of Cannabinoids in the Treatment of Angelman Syndrome
0 cites
US11633369utility2023
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US11590087utility2023
Cannabidiol-type Cannabinoid Compound
0 cites